BioFexhe: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
BioFexhe
Largest movements
- Tangible fixed assets -€1,569
down €1,569 (-13.7%), from €11,432 to €9,863
of which Plant, machinery and equipment: -€1,512
- Cash -€340
down €340 (-59.9%), from €567 to €227
- Receivables within one year -€215
down €215 (-64.9%), from €332 to €117
- Profit (loss) carried forward -€12,993
down €12,993 (-33.0%), from -€39,333 to -€52,326
- Other debts +€11,046
up €11,046 (+22.8%), from €48,400 to €59,446
- Trade debts -€177
down €177 (-81.4%), from €218 to €41
- Gross operating margin +€1,228
up €1,228 (+16.5%), from -€7,433 to -€6,205
- Financial charges +€255
up €255 (+54.4%), from €468 to €723
From the 2023 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
A cash bridge needs two consecutive fiscal years: one year's result and depreciation cannot explain a change over several years. Pick two years that follow each other.
Every line side by side
| Line | Code | 2023 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €12,331 | €10,207 | -€2,124 | -17.2% |
| Fixed assets | 21/28 | €11,432 | €9,863 | -€1,569 | -13.7% |
| Tangible fixed assets | 22/27 | €11,432 | €9,863 | -€1,569 | -13.7% |
| Land and buildings | 22 | €972 | €915 | -€57 | -5.9% |
| Plant, machinery and equipment | 23 | €10,461 | €8,948 | -€1,512 | -14.5% |
| Current assets | 29/58 | €899 | €344 | -€555 | -61.8% |
| Amounts receivable within one year | 40/41 | €332 | €117 | -€215 | -64.9% |
| Other amounts receivable | 41 | €332 | €117 | -€215 | -64.9% |
| Cash at bank and in hand | 54/58 | €567 | €227 | -€340 | -59.9% |
| Total equity and liabilities | 10/49 | €12,331 | €10,207 | -€2,124 | -17.2% |
| Equity | 10/15 | -€36,333 | -€49,326 | -€12,993 | -35.8% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Outside capital | 11 | €3,000 | - | -€3,000 | |
| Other | 1109/19 | €3,000 | - | -€3,000 | |
| Profit (loss) carried forward | 14 | -€39,333 | -€52,326 | -€12,993 | -33.0% |
| Amounts payable | 17/49 | €48,664 | €59,533 | +€10,869 | +22.3% |
| Amounts payable within one year | 42/48 | €48,618 | €59,487 | +€10,869 | +22.4% |
| Trade debts | 44 | €218 | €41 | -€177 | -81.4% |
| Suppliers | 440/4 | €218 | €41 | -€177 | -81.4% |
| Other amounts payable | 47/48 | €48,400 | €59,446 | +€11,046 | +22.8% |
| Accrued charges and deferred income | 492/3 | €46 | €46 | = | 0.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,569 | €1,569 | +€0 | 0.0% |
| Other operating charges | 640/8 | €796 | €836 | +€40 | +5.1% |
| Gross operating margin | 9900 | -€7,433 | -€6,205 | +€1,228 | +16.5% |
| Operating profit (loss) | 9901 | -€9,798 | -€8,610 | +€1,188 | +12.1% |
| Financial charges | 65/66B | €468 | €723 | +€255 | +54.4% |
| Recurring financial charges | 65 | €468 | €723 | +€255 | +54.4% |
| Profit (loss) for the period before taxes | 9903 | -€10,267 | -€9,333 | +€933 | +9.1% |
| Profit (loss) for the period | 9904 | -€10,267 | -€9,333 | +€933 | +9.1% |
| Profit (loss) for the period to be appropriated | 9905 | -€10,267 | -€9,333 | +€933 | +9.1% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2023 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 1 October 2026 via checked.be.